-
Yes there is a genomics based test for this now, male and female. Inquiring minds want to know. If the answer comes back yes, then get a hold of some Propecia ©. If you have the gene variant, you have approximately a 70% chance of going bald, and the same in reverse if you do not have...
-
In this interview article McKesson discusses visualization and showing the physicians the information they that need to know at the point of decision making at the point of care. The EHR will have to support genetic knowledge. They are working with Proventys to create an integrated product...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
10-09-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, personalized medicine, healthcare, Medical Records, EHR, McKesson, Hospitals, Pharmacogenomics, Horizon
-
I would say genomics and personalized medicine is a very hot topic and developing fast, based on 4 machines being ordered from Singapore. Just this week Stanford university ordered their single sequencing machines from Helicos. Stay tuned and there’s plenty of sequencing and personalized...
-
This article states part of the reporting system will include information on the willingness of a doctor to use genetic testing, well first of all we need to help the doctors to bring this full circle with the integration into the clinical side of this, as I have spoken to many MDs and they are aware...
-
How hot is genomics today? There are several manufacturers of the machines that will accomplish running our DNA, our complete DNA. I know to the average person this gets a little confusing, but the companies listed here are the companies that manufacture the machines that do the entire work...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-25-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, My Commentaries, personalized medicine, Genomics, Biotech, Pharmacogenomics, DNA Testing, Helicos, Sequencing, RNA
-
Genomics is back on the list for Congress, with creating an additional new agency and a focus on collecting the necessary information to allow research and development. Also included would be guidelines and rules related to genetic and pharmacogenomic tests to bring both Pharma and medical...
-
If you want to do some reading up on the topic, this site may offer some help, along with the upcoming conference to be held here in the Los Angeles area in October. As posted recently there are plans for many of the service companies, such as 23andMe , Navigenics , DeCode, LabCorp , and perhaps...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
09-11-2008
Filed under:
Filed under: Medically Related, Pharma/FDA News, My Commentaries, Physician, personalized medicine, Genomics, Cancer, Pharmacogenomics, Patients, Genonimic Testing, Human Genome Project, Genomic Counseling, Lab Tests
-
After all the recent news about the PSA test, here's a genomics answer. The MD Anderson Cancer Center, demonstrated a very high success rate for identifying the presence of Grade 3 or higher prostate cancer cells. The new prostate cancer test will be performed at Clarient's Clinical...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
08-07-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, personalized medicine, DNA, Genomics, Prostate Cancer, Pharmacogenomics, PSA, Cancer Test
-
The software offers both detailed, localized views of genomic data, and a whole genome view, in a format somewhat similar to the way Google presents items on the web. It is free to download and use. There are also some sample data files available. I like the idea of the heat map view...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
08-06-2008
Filed under:
Filed under: Medically Related, Technology, Pharma/FDA News, Other Items of Interest, DNA, Genomics, Research, Pharmacogenomics, MIT, Biomed, Broad Institute, Harvard
-
The program uses just plain old Java, but add this technology with sequencing information and with the 4D applications, studies can be virtually conducted to see how a medication would react with selected settings. Its resolution is scaleable to 100,000,000 pixels and more by using more than one...
-
This is good, a genomics test that can give some preliminary results on whether or not statins will have an adverse effect before prescribing them. As the post states here, this is something that could certainly use some marketing to physicians. Zocor at 40 mg is a very common dosage and...
-
More business action with big pharma and the biotech industry, although Roche and Genentech already are invested together and have worked on conjunction on research projects. Roche acquired a majority in Genentech in 1990 and currently owns 55.9% of all outstanding shares. Roche...
-
Not too many years ago I remembered hearing the term “hospitalist” and asked what’s that? The hospitalist has evolved and is now one of the top growing professions. With Pharmacogenomics, we might be on the verge of a new specialty, a “Longevity Doctor”. We already have a dwindling...
-
Pfizer is wasting no time to get the calculations running and numbers rolling. To stay in the market, they are attempting to find out as much as they can about potential side effects and other perhaps adverse affects of their drugs. Better than they find up them front, as it will make for better...
-
We all recently heard about the warning letters sent from the state of California to firms selling online personal DNA sequencing over the Internet, and requiring a physician’s prescription for the service. One company DeCode, has taken the letter to heart and is revising their marketing plant...
Posted to
The Medical Quack .... by Barbara Duck
by
The Medical Quack
on
07-12-2008
Filed under:
Filed under: Medically Related, Insurance, Pharma/FDA News, personalized medicine, DNA, Genomics, Sequence, Pharmacogenomics, Diagnostics, CPT, DeCode